CACA胃癌整合诊治指南(精简版)

China Anti-Cancer Association guidelines for holistic integrative management of gastric cancer(Lite Version)

胃癌是世界常见恶性肿瘤之一。在中国,胃癌发病率与死亡率均居第3位。近年来,随着诊疗技术的提高及重点人群筛查的实施,胃癌患者的5年生存率逐渐提升,但与日韩等胃癌治疗先进国家相比仍处于较低水平,亟需一部体现中国特色的诊疗指南指导胃癌的防治工作。中国抗癌协会(CACA)整合诊治指南是在总会指导下,由胃癌专委会具体完成的。这是目前为止纳入胃癌相关学科体系最为完整的一部指南,秉承“全人、全身、全程、全息”理念,关注“防-筛-诊-治-康”全程管理,体现学科融合、技术整合、多学科整合诊疗(multi-disciplinary team to holistic integrative medicine,MDT to HIM)的理念,聚焦中国人群的流行病学特征、遗传背景、原创研究成果及诊疗防控特色,纳入国内研究,兼顾医疗可及性,突出中医特色和我国癌症防控经验,体现了“研究证据-医生经验-患者需求”的整合。本指南为全国同道推荐证据类别高、可及性好、最具临床实操指导价值的诊治方案,可以更有针对性的指导中国的胃癌防治工作,改善中国胃癌患者预后,助力健康中国战略。

Gastric cancer is a common malignant tumor worldwide.In China,both the morbidity and mortality rates of gastric cancer rank third.Recently,with the improvement of diagnostic technology and screening implementation,the 5-year survival rate of patients with gastric cancer has gradually increased;however,it remains at a low level compared to that of Japan,South Korea,and other developed countries.Therefore,a guideline with Chinese characteristics for the prevention and treatment of gastric cancer is immediately needed.The integrative guideline of gastric cancer was accomplished by the Society of Gastric Cancer under the guidance of the China Anti-Cancer Association(CACA).This is the most comprehensive guideline,which incorporated the discipline system of gastric cancer.Adhering to the concept of the“whole person,whole body,whole process,and holographics,”we focused on the overall process management of preventing,screening,diagnosing,treating,and rehabilitating,which embodies the integration of discipline and technology and concepts of multi-disciplinary team to holistic integrative medicine(MDT to HIM).The guideline focused on the Chinese epidemiology,genetic background,and characteristics of diagnosis and prevention,included the Chinese original studies and medical accessibility,highlighted the traditional Chinese medicine and history,and reflected the integration of study evidence,doctor experience,and patient needs.The guideline recommended that the management project with greater evidence,better accessibility,and higher clinical practice guidance value in China,which can be more pertinent for prevention and treatment,may improve the prognosis of patients with gastric cancer and contributes to conduct the“Healthy China Initiative.”